共 164 条
[1]
Fulda S(2009)Tumor resistance to apoptosis Int J Cancer 124 511-515
[2]
Shah K(2019)Genetic and epigenetic modulation of drug resistance in cancer: challenges and opportunities Curr Drug Metab 20 1114-1131
[3]
Rawal RM(2009)Histone deacetylase inhibitors in cancer therapy J Clin Oncol 27 5459-5468
[4]
Lane AA(2009)Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications Clin Cancer Res 15 3947-3957
[5]
Chabner BA(2007)Histone deacetylase inhibitors: molecular mechanisms of action Oncogene 26 5541-5552
[6]
Schrump DS(2020)HDAC6-an emerging target against chronic myeloid leukemia? Cancers 12 318-348
[7]
Xu WS(2007)Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator J Biol Chem 282 35594-35603
[8]
Parmigiani RB(2009)Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region Mol Cancer Res 7 735-744
[9]
Marks PA(2007)Mechanisms of resistance to histone deacetylase inhibitors and their therapeutic implications Clin Cancer Res 13 7237-7242
[10]
Losson H(2011)Histone deacetylase inhibitors: emerging mechanisms of resistance Mol Pharm 8 2021-2031